Open access
1,042
Views
1
CrossRef citations to date
0
Altmetric
Clinical Trials
Patient-reported outcomes validated in phase 3 clinical trials: a targeted literature review
Antonia Morgaa Astellas Pharma Europe Ltd, Addlestone, UKCorrespondence[email protected]
, Silvia Dibenedettob Mapi Research Trust, Lyon, France
, Rocco Adiutorib Mapi Research Trust, Lyon, France
& Jun Suc Astellas Pharma Inc, Westborough, MA, USA
Pages 955-962
|
Received 09 Feb 2023, Accepted 08 Jun 2023, Published online: 30 Jun 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.